how to optimize access to car-t cell therapies in multiple myeloma
Published 1 year ago • 120 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
2:57
strategies to optimize car-t therapy in myeloma: bringing car-t into earlier lines
-
2:49
novel strategies to optimize car-t therapy in myeloma
-
1:12
optimizing car-t therapy for patients with multiple myeloma in the real-world
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
4:14
challenges with the real-world use of car-t therapy in multiple myeloma
-
3:06
management of multiple myeloma during car-t therapy manufacturing
-
1:07
optimizing car-t therapy: regulating car t-cells in vivo
-
1:38
real world use of car t-cell therapy in multiple myeloma
-
15:50
understanding car t therapy: a groundbreaking approach to myeloma treatment
-
58:59
car-t cell therapy: current uses and future possibilities
-
15:06
how to give car-t cells a boost
-
1:38
challenges of car-t therapy in the real-world setting
-
4:04
overcoming challenges in car t-cell therapy for multiple myeloma
-
0:57
focusing on allogeneic car t-cell therapies for myeloma
-
2:18
moving forward: bringing car-t therapy to a frontline setting in myeloma
-
0:46
challenges associated with the use of off-the-shelf car-t products in multiple myeloma
-
2:10
optimizing car-t therapy in lbcl
-
1:22
the potential use of car-t therapy following autologous transplantation in multiple myeloma
-
2:40
car t-cell therapy to revolutionize multiple myeloma?
-
1:21
developing off-the-shelf car t-cells to treat multiple myeloma
-
3:59
strategies to improve car t-cell manufacturing
-
3:27
car-t cells in myeloma